TP53 and neoplasm: Possible reasons for the conflicting results include the type of statin used (lipophilic statins being more readily taken up by cells than hydrophilic statins), dose administered, length of treatment, co-administered drug(s), whether the treatment was started before or after diagnosis and whether or not the tumor undergoing treatment contained p53 mutations (and possibly the type of mutation).